Skin Cancer Metabolic Profile Assessed by Different Analytical Platforms
- PMID: 36675128
- PMCID: PMC9866771
- DOI: 10.3390/ijms24021604
Skin Cancer Metabolic Profile Assessed by Different Analytical Platforms
Abstract
Skin cancer, including malignant melanoma (MM) and keratinocyte carcinoma (KC), historically named non-melanoma skin cancers (NMSC), represents the most common type of cancer among the white skin population. Despite decades of clinical research, the incidence rate of melanoma is increasing globally. Therefore, a better understanding of disease pathogenesis and resistance mechanisms is considered vital to accomplish early diagnosis and satisfactory control. The "Omics" field has recently gained attention, as it can help in identifying and exploring metabolites and metabolic pathways that assist cancer cells in proliferation, which can be further utilized to improve the diagnosis and treatment of skin cancer. Although skin tissues contain diverse metabolic enzymes, it remains challenging to fully characterize these metabolites. Metabolomics is a powerful omics technique that allows us to measure and compare a vast array of metabolites in a biological sample. This technology enables us to study the dermal metabolic effects and get a clear explanation of the pathogenesis of skin diseases. The purpose of this literature review is to illustrate how metabolomics technology can be used to evaluate the metabolic profile of human skin cancer, using a variety of analytical platforms including gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and nuclear magnetic resonance (NMR). Data collection has not been based on any analytical method.
Keywords: analytical platforms; biomarkers; cancer; metabolic profile; metabolomic; omics; proteomic; skin cancer.
Conflict of interest statement
The authors declare no conflict of interest in relation to this study. This research is part of the -Human Disease Biomarkers Discovery Research Group-study.
Figures
Similar articles
-
The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?J Pharm Biomed Anal. 2018 Jan 30;148:273-279. doi: 10.1016/j.jpba.2017.10.013. Epub 2017 Oct 18. J Pharm Biomed Anal. 2018. PMID: 29059617
-
New findings on urinary prostate cancer metabolome through combined GC-MS and 1H NMR analytical platforms.Metabolomics. 2020 Jun 3;16(6):70. doi: 10.1007/s11306-020-01691-1. Metabolomics. 2020. PMID: 32495062
-
Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.Adv Exp Med Biol. 2017;965:77-98. doi: 10.1007/978-3-319-47656-8_4. Adv Exp Med Biol. 2017. PMID: 28132177 Review.
-
A review of strategies for untargeted urinary metabolomic analysis using gas chromatography-mass spectrometry.Metabolomics. 2020 May 18;16(6):66. doi: 10.1007/s11306-020-01687-x. Metabolomics. 2020. PMID: 32419109 Review.
-
Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.Prog Nucl Magn Reson Spectrosc. 2017 May;100:1-16. doi: 10.1016/j.pnmrs.2017.01.001. Epub 2017 Jan 11. Prog Nucl Magn Reson Spectrosc. 2017. PMID: 28552170 Free PMC article. Review.
Cited by
-
Cutaneous Melanoma and 486 Human Blood Metabolites: A Mendelian Randomization Study.Aesthetic Plast Surg. 2024 Jul;48(13):2545-2552. doi: 10.1007/s00266-024-03873-x. Epub 2024 Mar 4. Aesthetic Plast Surg. 2024. PMID: 38438761
-
The Potential Diagnostic Utility of SMAD4 and ACCS in the Context of Inflammation in Type 2 Diabetes Mellitus Patients.Biomedicines. 2024 Sep 4;12(9):2015. doi: 10.3390/biomedicines12092015. Biomedicines. 2024. PMID: 39335530 Free PMC article.
-
Exploring Human Metabolome after Wine Intake-A Review.Molecules. 2023 Nov 15;28(22):7616. doi: 10.3390/molecules28227616. Molecules. 2023. PMID: 38005338 Free PMC article. Review.
-
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications.Pract Lab Med. 2024 Dec 24;43:e00446. doi: 10.1016/j.plabm.2024.e00446. eCollection 2025 Jan. Pract Lab Med. 2024. PMID: 39839814 Free PMC article. Review.
-
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.ACS Omega. 2024 Feb 22;9(9):10030-10048. doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5. ACS Omega. 2024. PMID: 38463249 Free PMC article. Review.
References
-
- Toğaçar M., Cömert Z., Ergen B. Intelligent skin cancer detection applying autoencoder, MobileNetV2 and spiking neural networks. Chaos Solitons Fractals. 2021;144:110714. doi: 10.1016/j.chaos.2021.110714. - DOI
-
- Haggenmüller S., Maron R.C., Hekler A., Utikal J.S., Barata C., Barnhill R.L., Beltraminelli H., Berking C., Betz-Stablein B., Blum A., et al. Skin cancer classification via convolutional neural networks: Systematic review of studies involving human experts. Eur. J. Cancer. 2021;156:202–216. doi: 10.1016/j.ejca.2021.06.049. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous